Drug & intervention

creatine

RxCUI 2907

Clinical trials6
Recruiting0
Related conditions4
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Creatine

Creatine ( or ) is an organic compound that facilitates recycling of adenosine triphosphate (ATP) in vertebrates, primarily in their muscle and brain tissue. It is a popular dietary supplement. Its phosphorylated form, phosphocreatine, donates phosphate groups to adenosine diphosphate (ADP), turning it back into ATP. Creatine also acts as a buffer. It has the nominal formula (H2N)(HN)CN(CH3)CH2CO2H. In solutions, it exists in various tautomers, including a neutral form and zwitterionic forms.

Read on Wikipedia ↗ Wikidata Q223600 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

6 shown
Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy TreatmentNCT07372144 · 2026-08-01
NOT_YET_RECRUITING
Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive DisorderNCT02134808 · 2014-11-21
COMPLETED
Creatine Augmentation in Veterans With SSRI-Resistant Major DepressionNCT01175616 · 2012-09-01
WITHDRAWN
NET-PD LS-1 Creatine in Parkinson's DiseaseNCT00449865 · 2007-03-01
TERMINATED
Creatine Treatment in Psychiatric DisordersNCT00140192 · 2004-09-01
COMPLETED
National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection TrialNCT00063193 · 2003-05-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.